Ligation of CD44 with low-molecular-weight hyaluronan and a monoclonal antibody leads to inhibition of drug-induced apoptosis in a human myeloid cell line

Hematology

Volumn 14, Issue 4, 2009, Pages 213-219

  Onoda, Masahiro ^a   Nakaseko, Chiaki ^b   Yokota, Akira ^a   Saito, Yasushi ^b  

^a CHIBA AOBA MUNICIPAL HOSPITAL   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; CD44; Hematopoietic progenitor cells; Hyaluronan

Indexed keywords

CD33 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CYTARABINE; GENISTEIN; HERMES ANTIGEN; HYALURONIC ACID; MICROSOMAL AMINOPEPTIDASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD44; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG; LIGAND; TYROSINE;

APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL INTERACTION; CELL SURVIVAL; CONTROLLED STUDY; DRUG POTENTIATION; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; ACUTE GRANULOCYTIC LEUKEMIA; BIOSYNTHESIS; CYTOLOGY; DRUG EFFECT; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION; TUMOR CELL LINE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD44; APOPTOSIS; CELL LINE, TUMOR; GENISTEIN; HEMATOPOIETIC STEM CELLS; HUMANS; HYALURONIC ACID; LEUKEMIA, MYELOID, ACUTE; LIGANDS; MOLECULAR WEIGHT; MYELOID CELLS; PHOSPHORYLATION; TYROSINE;

EID: 70349906647     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453309X426236     Document Type: Article

References (35)

1. Droz D, Patey N, Paraf F, Chretien Y, Gogusev J. Composition of extracellular matrix and distribution of cell adhesion molecules in renal cell tumors. Lab Invest 1994; 71: 710-718.
2. Simmons PJ, Levesque JP, Zannettino AC. Adhesion molecules in haemopoiesis. Baillieres Clin Haematol 1997; 10: 485-505.
3. Miyake K, Medina KL, Hayashi S, Ono S, Hamaoka T, Kincade PW. Monoclonal antibodies to Pgp-1/CD44 block lymphohemopoiesis in long-term bone marrow cultures. J Exp Med 1990; 171: 477-488.
4. Miyake K, Weissman IL, Greenberger JS, Kincade PW. Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis. J Exp Med 1991; 173: 599-607.
5. Larkin J, Renukaradhya GJ, Sriram V, Du W, Gervay-Hague J, Brutkiewicz RR. CD44 differentially activates mouse NK T cells and conventional T cells. J Immunol 2006; 177: 268-279.
6. Rafi A, Nagarkatti M, Nagarkatti PS. Hyaluronate-CD44 interactions can induce murine B-cell activation. Blood 1997; 89: 2901-2908.
7. Termeer C, Averbeck M, Hara H et al. Targeting dendritic cells with CD44 monoclonal antibodies selectively inhibits the proliferation of naive CD4z T-helper cells by induction of FASindependent T-cell apoptosis. Immunology 2003; 109: 32-40.
8. Sugahara KN, Murai T, Nishinakamura H, Kawashima H, Saya H, Miyasaka M. Hyaluronan oligosaccharides induce CD44 cleavage and promote cell migration in CD44-expressing tumor cells. J Biol Chem 2003; 278: 32259-32265.
9. Yokota A, Ishii G, Sugaya Y, Nishimura M, Saito Y, Harigaya K. Expression of exon v6-containing CD44 isoforms is related to poor prognosis of acute myelocytic leukemia. Hematol Oncol 1998; 16: 131-141.
10. Jin L, Hope KJ, Zhai Q, Smadja-Joffe F, Dick JE. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med 2006; 12: 1167-1174. (Pubitemid 44527352)
11. Krause DS, Lazarides K, von Andrian UH, Van Etten RA. Requirement for CD44 in homing and engraftment of BCR-ABLexpressing leukemic stem cells. Nat Med 2006; 12: 1175-1180.
12. Gallagher JT, Spooncer E, Dexter TM. Role of the cellular matrix in haemopoiesis. I. Synthesis of glycosaminoglycans by mouse bone marrow cell cultures. J Cell Sci 1983; 63: 155-171.
13. Allouche M, Bettaieb A, Vindis C, Rousse A, Grignon C, Laurent G. Influence of Bcl-2 overexpression on the ceramide pathway in daunorubicin-induced apoptosis of leukemic cells. Oncogene. 1997;14: 1837-1845.
14. Schenck P, Schneider S, Miehlke R, Prehm P. Synthesis and degradation of hyaluronate by synovia from patients with rheumatoid arthritis. J Rheumatol 1995; 22: 400-405.
15. Forrester JV, Balazs EA. Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology 1980; 40: 435-446.
16. Hodge-Dufour J, Noble PW, Horton MR et al. Induction of IL-12 and chemokines by hyaluronan requires adhesion-dependent priming of resident but not elicited macrophages. J Immunol 1997; 159: 2492-2500.
17. Nakano K, Saito K, Mine S, Matsushita S, Tanaka Y. Engagement of CD44 up-regulates Fas ligand expression on T cells leading to activation-induced cell death. Apoptosis 2007; 12: 45-54.
18. Koeffler HP, Billing R, Lusis AJ, Sparkes R, Golde DW. An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1). Blood 1980; 56: 265-273.
19. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 1986; 89: 271-277.
20. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994; 84: 1415-1420.
21. Allouche M, Charrad RS, Bettaieb A, Greenland C, Grignon C, Smadja-Joffe F. Ligation of the CD44 adhesion molecule inhibits drug-induced apoptosis in human myeloid leukemia cells. Blood 2000; 96: 1187-1190.
22. Laskin DL, Soltys RA, Berg RA, Riley DJ. Activation of alveolar macrophages by native and synthetic collagen-like polypeptides. Am J Respir Cell Mol Biol 1994; 10: 58-64.
23. Slevin M, Krupinski J, Kumar S, Gaffney J. Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. Lab Invest 1998; 78: 987-1003.
24. Montesano R, Kumar S, Orci L, Pepper MS. Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro. Lab Invest 1996; 75: 249-262.
25. Rooney P, Kumar S. Inverse relationship between hyaluronan and collagens in development and angiogenesis. Differentiation 1993; 54: 1-9.
26. Anstee DJ, Gardner B, Spring FA et al. New monoclonal antibodies in CD44 and CD58: their use to quantify CD44 and CD58 on normal human erythrocytes and to compare the distribution of CD44 and CD58 in human tissues. Immunology 1991; 74: 197-205.
27. Denning S, Telen M, Liao H, Haynes B. CD44H and CD44R cluster report. In: Schossman S, Boumsell L and Gilks W (ed) Leukocyte typing V: white cell differentiation antigens. Oxford: Oxford University Press, 1995; 1713-1719.
28. Bendall LJ, Kirkness J, Hutchinson A et al. Antibodies to CD44 enhance adhesion of normal CD34+ cells and acute myeloblastic but not lymphoblastic leukaemia cells to bone marrow stroma. Br J Haematol 1997; 98: 828-837.
29. Oostendorp RA, Spitzer E, Brandl M, Eaves CJ, Dormer P. Evidence for differences in the mechanisms by which antibodies against CD44 promote adhesion of erythroid and granulopoietic progenitors to marrow stromal cells. Br J Haematol 1998; 101:436-445.
30. Charrad RS, Li Y, Delpech B et al. Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia. Nat Med 1999; 5: 669-676.
31. Lesley J, English N, Perschl A, Gregoroff J, Hyman R. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J Exp Med 1995; 182: 431-437.
32. Smadja-Joffe F, Legras S, Girard N et al. CD44 and hyaluronan binding by human myeloid cells. Leuk Lymphoma 1996; 21: 407-420, color plates following 528.
33. Legras S, Levesque JP, Charrad R et al. CD44-mediated adhesiveness of human hematopoietic progenitors to hyaluronan is modulated by cytokines. Blood 1997; 89: 1905-1914. (Pubitemid 27132104)
34. Hannun YA, Obeid LM. Ceramide: an intracellular signal for apoptosis. Trends Biochem Sci 1995; 20: 73-77.
35. Mansat V, Laurent G, Levade T, Bettaieb A, Jaffrezou JP. The protein kinase C activators phorbol esters and phosphatidylserine inhibit neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin. Cancer Res 1997; 57:5300-5304.